Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Bal Pharma appoints S...

    Bal Pharma appoints S Anika Mercylin as CS, Compliance Officer

    Farhat NasimWritten by Farhat Nasim Published On 2018-12-29T09:45:10+05:30  |  Updated On 29 Dec 2018 9:45 AM IST
    Bal Pharma appoints S Anika Mercylin as CS, Compliance Officer

    New Delhi: Drug major Bal Pharma recently appointed Ms S Anika Mercylin as the Company Secretary and Compliance Officer.


    The company stated in a BSE filing, "as per the provisions of Section 203 of the Companies Act,2013, the Board of Directors of the Company at their meeting held has inter alia appointed Ms.S.Anika Mercylin (M.No A41933) as Company Secretary and Compliance officer of the Company."


    Ms.S.Anika Mercylin, an ACS qualified has been appointed on terms as per the HR policy of the company.


    Ms S Anika Mercylin has attended Institute of Company Secretaries of India. She possesses two years experience of Company Secretaryship.


    The filing further added a disclosure," She is not related to any Directors or KMP's of the relationship with Directors & KMP's Company.


    "As per the provisions of Regulation 30(5) of SEBI(LODR) Regulations, 2015, Ms.Anika Mercylin was also authorized by the Board for the purpose of determining the materiality of event or information and to disclose the same to the exchange within the specific period."


    Bal Pharma is an Indian Pharmaceutical Company with 25 years of experience, specialized in Prescription Drugs, Generic & OTC Products, Intravenous Infusion and Bulk Actives.






    Bal Pharma’s API are largely exported to Europe, the Far East, Latin America, Africa, the Middle East and other World markets. The FDF is exported to Semi-Regulated, Non-Regulated market.

    Also Read: Bal Pharma commenses commercial production at Udaipur unit


    bal pharmacompany secretarycompliance officerpharmaceuticals anika mercylinSEBI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok